Arginic succinic acid syndrome E72.2

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Allan dent-disease; Arginic Succinic Acid Bullshit; Arginine Succinaturia; argininosuccinic aciduria; Argininosuccino aciduria; ASA deficiency; ASL deficiency; OMIM 207900

History
This section has been translated automatically.

Allen, 1958

Definition
This section has been translated automatically.

Rare, autosomal-recessive inherited metabolic disorder of the urea cycle caused by arginine succinate lyase deficiency with pathological manifestations in the nervous system, hair (often trichorrhexis nodosa) and liver.

Occurrence/Epidemiology
This section has been translated automatically.

The incidence is 1:70,000.

Etiopathogenesis
This section has been translated automatically.

Autosomal recessive mutations of the argininosuccinate lyase gene (ASL gene; gene locus 7cen-q11.2) with consecutive metabolic disorder of the urea cycle, which leads to accumulation of arginic succinic acid in plasma and urine and to hyperammonemia in case of arginine succinate lyase deficiency.

Manifestation
This section has been translated automatically.

Usually from birth.

Clinical features
This section has been translated automatically.

Brittle, brittle, dull, difficult to style hair, especially at the back of the head; delayed hair growth. Neurological symptoms: spasms, ataxia, retardation of mental development; liver involvement. There are three different clinical forms after initial manifestation:
  • Neonatal form: Beginning in the first days of life; increasing apathy, weakness in drinking, muscular hypotension and cramps. Prognosis: Without therapy lethal.
  • Infantile form: Beginning in the 1st year of life; episodes of recurrent vomiting, tremor and seizures up to coma; usually leads to physical and mental retardation.
  • Chronic form: Beginning after the 1st year of life; the children are only noticed by the delay in development; frequent are seizures, intermittent ataxia and lethargy caused by protein intake or infections. However, these patients can also develop normally on a protein-reduced diet. Marked arginine succinatemia, depending on the protein intake also hyperammonemia, citrullinemia.

Histology
This section has been translated automatically.

Trichorrhexis nodosa, circumscribed, bristle-brush-like splits of the hair cuticle.

Diagnosis
This section has been translated automatically.

Detection of arginic succinic acid in urine by paper chromatography.

Differential diagnosis
This section has been translated automatically.

Therapy
This section has been translated automatically.

Restriction of protein intake. Substitution of arginine (e.g. 1 M L-arginine hydrochloride solution Pfrimmer) 3 mmol/kg bw/day. Immediate symptomatic therapy of hyperammonemia; long-term therapy with low-protein diet and arginine substitution (possibly citrate administration in case of elevated citrulline levels!) Prenatal diagnosis from amniotic cells and chorionic biopsy possible.

Literature
This section has been translated automatically.

  1. Allan JD, Cusworth DC, Dent CE, Wilson UK (1958) Disease, probably hereditary, characterized by severe mental deficiency and constant gross abnormality of amino acid metabolism. Lancet I: 182-187
  2. Gieselmann V (2003) Metachromatic leukodystrophy: recent research developments. J Child Neurol 18: 591-594
  3. Kleijer WJ et al (2002 Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis 25: 399-410
  4. Linnebank M et al (2002) Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene. Hum Genet 111: 350-359

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020